Ann: OmniCAR technical issues resolved and program to progress, page-34

It is certainly an exciting time in regards to Omnicar l am so glad that the team under Prof Phil Darcy got on top of their technical hiccup. Also I would think James would notify shareholders / the market in regard to the phase 2 PTX 100 starting to treat patients, hopefully after 8 to 12 weeks we might get some feedback from Prof Miles Prince with some ongoing results from the patients. I would think the results will be quite favourable from this new group of patients as they have only had one or two treatments before being treated with the PTX 100 as the old cohort of patients had four or five treatments before starting and were quite unwell at the beginning of treatment program. All in all things are looking very positive, other than the share price which I’m sure will correct itself in the near future.